Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
This patent details a copper-catalyzed synthesis for 1-naphthylamine derivatives offering high yields. It enables cost reduction and scalable manufacturing for reliable pharmaceutical intermediate suppliers globally.
Patent CN113045489A reveals a novel Pd-catalyzed aminocarbonylation route for high-purity API intermediates, offering significant cost reduction and scalable manufacturing.
Patent CN113307778A reveals a novel Mo/Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering cost reduction in API manufacturing and scalable production.
Patent CN118619879A reveals a novel Rh-catalyzed method for trifluoromethyl enaminones. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable processes.
Patent CN113461589B details a novel one-step asymmetric Friedel-Crafts reaction for chiral 2,3-disubstituted indoleamines, offering significant cost reduction in API manufacturing.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of key heterocyclic building blocks.
Novel chiral phosphoric acid catalyzed synthesis of indoxazinones with high enantioselectivity and mild conditions for anticancer drug development.
Patent CN107936025B details a metal-free NHC catalytic route for high-purity chiral intermediates, offering significant cost reduction in API manufacturing and scalable supply.
Patent CN111978265B reveals a novel FeCl3-catalyzed route for 5-trifluoromethyl-1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable production.
Patent CN114160206B reveals a novel chiral copper catalyst for optically active indoles. Achieve >91% ee and substantial cost reduction in API manufacturing with scalable processes.
Patent CN102153433B details an aerobic oxidative synthesis of N-monosubstituted-alpha-carbonylamides. This method offers significant cost reduction in pharmaceutical intermediate manufacturing via mild, scalable conditions.
Patent CN113121462B reveals a safe, metal-free synthesis for 5-trifluoromethyl-1,2,3-triazoles. Discover cost-effective manufacturing and supply chain advantages.
Advanced microchannel synthesis of O-(3-chloro-2-propenyl) hydroxylamine offers high purity and cost reduction in agrochemical intermediate manufacturing for global herbicide production.
Advanced ruthenium-catalyzed synthesis of polyaromatic naphthalene derivatives for optoelectronics. Cost-effective, scalable, and high-purity manufacturing solutions.
Patent CN113045489B details a novel Pd-catalyzed route to 3-arylquinolin-2(1H)ones using benzisoxazole, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN114380743B reveals transition-metal-free trifluoromethylthiolation enhancing lipophilicity and bioavailability for pharmaceutical intermediates with superior atom economy.
Patent CN105622493B reveals metal-free pyridine synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN113307778A reveals a novel Mo/Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering cost reduction in API manufacturing and scalable production.
Novel iodine-promoted method for 3,4,5-trisubstituted 1,2,4-triazoles offers cost-effective, scalable routes for API manufacturing without heavy metals.
Novel Rh-catalyzed C-H activation for trifluoromethyl enaminones. High purity, scalable process for pharmaceutical and agrochemical intermediates.